Cargando…

Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study

While it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shiwei, Wang, Yue, Yao, Wei, Yue, Peng, Guo, Fuyu, Deng, Xiaoqian, Zhang, Jiandong, Zhang, Yangang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475110/
https://www.ncbi.nlm.nih.gov/pubmed/37660207
http://dx.doi.org/10.1038/s41598-023-41839-2
_version_ 1785100649691611136
author Sun, Shiwei
Wang, Yue
Yao, Wei
Yue, Peng
Guo, Fuyu
Deng, Xiaoqian
Zhang, Jiandong
Zhang, Yangang
author_facet Sun, Shiwei
Wang, Yue
Yao, Wei
Yue, Peng
Guo, Fuyu
Deng, Xiaoqian
Zhang, Jiandong
Zhang, Yangang
author_sort Sun, Shiwei
collection PubMed
description While it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. This study enrolled 5448 patients with adrenal masses from the SEER Program. The influencing factors were selected using the least absolute shrinkage and selection operator regression model (LASSO) and Fine and Gray model (FGM). In addition, nomograms were constructed. Receiver operating characteristic curves and bootstrap self-sampling methods were used to verify the discrimination and consistency of the nomograms. The independent influencing factors for PAL survival were selected by LASSO and FGM, and three models were built: the OS, DSS, and FGS (DSS analysis by FGM) model. The areas under the curve and decision curve analyses indicated that the models were valid. This study developed survival prediction models to predict OS and DSS of patients with PAL. The FGS model was more accurate than the DSS model in the short term. Above all, these models should offer benefits to patients with PAL in terms of the treatment modality choice and survival evaluation.
format Online
Article
Text
id pubmed-10475110
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104751102023-09-04 Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study Sun, Shiwei Wang, Yue Yao, Wei Yue, Peng Guo, Fuyu Deng, Xiaoqian Zhang, Jiandong Zhang, Yangang Sci Rep Article While it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. This study enrolled 5448 patients with adrenal masses from the SEER Program. The influencing factors were selected using the least absolute shrinkage and selection operator regression model (LASSO) and Fine and Gray model (FGM). In addition, nomograms were constructed. Receiver operating characteristic curves and bootstrap self-sampling methods were used to verify the discrimination and consistency of the nomograms. The independent influencing factors for PAL survival were selected by LASSO and FGM, and three models were built: the OS, DSS, and FGS (DSS analysis by FGM) model. The areas under the curve and decision curve analyses indicated that the models were valid. This study developed survival prediction models to predict OS and DSS of patients with PAL. The FGS model was more accurate than the DSS model in the short term. Above all, these models should offer benefits to patients with PAL in terms of the treatment modality choice and survival evaluation. Nature Publishing Group UK 2023-09-02 /pmc/articles/PMC10475110/ /pubmed/37660207 http://dx.doi.org/10.1038/s41598-023-41839-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sun, Shiwei
Wang, Yue
Yao, Wei
Yue, Peng
Guo, Fuyu
Deng, Xiaoqian
Zhang, Jiandong
Zhang, Yangang
Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
title Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
title_full Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
title_fullStr Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
title_full_unstemmed Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
title_short Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
title_sort development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475110/
https://www.ncbi.nlm.nih.gov/pubmed/37660207
http://dx.doi.org/10.1038/s41598-023-41839-2
work_keys_str_mv AT sunshiwei developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT wangyue developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT yaowei developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT yuepeng developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT guofuyu developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT dengxiaoqian developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT zhangjiandong developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy
AT zhangyangang developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy